Le Lézard
Classified in: Covid-19 virus
Subject: OBI

A CELEBRATION OF LIFE HONOURING DAVID N. TAVARES


TORONTO, June 7, 2022 /CNW/ - The Tavares family will be hosting a Celebration of Life and Legacy Event honouring Mr. David Nicodemio Tavares on Wednesday June 8, 2022, from 6:00pm ? 9:00pm at Massey Hall, 728 Victoria Street, Toronto, ON M5H 1S5. The Regional Undersecretary for the Regional Government of the Azores, President of the Municipal City Hall for Ponta Delgada, Deputy Mayor, former Minister of Finance for Ontario and former Mayor of Mississauga will pay tribute to an entrepreneur and pioneer in the Canadian Portuguese community.

Dignitaries celebrating the life and legacy of David N. Tavares

Mr. David N. Tavares passed away at the young age of 72, on Wednesday January 13, 2021 after a battle with cancer during the Covid-19 pandemic province wide shutdown. As a result, family, friends and colleagues were unable to pay their respects until restrictions were removed. The family is pleased to organize a memorial service to celebrate the life of David N. Tavares by bringing together family, friends and colleagues from around the world to Toronto. The event will be live streamed from our social media sites - (https://youtu.be/g01l6TxZLdw)

David was a visionary and pioneering Canadian entrepreneur who immigrated to Canada from Sao Miguel, Azores, Portugal in 1966. He made Canada his place to grow and applied his technical ingenuity,  with a passion for developing technological solutions, to serve the world. He used the same passion he had for everything Canadian by creating a strong Canada-Azores-Portugal partnership to promote economic opportunity for his native Azores. David was a humble man and all about giving back. He founded his enterprises with the mission to grow and serve people, using technology as a means to improve peoples' daily lives on a global scale.

Founding several enterprises spanning the five decades of his career, David's most notable GlobeStar Systems Inc., the developer of the Connexall enterprise software platform used in hospitals around the world. Connexall has become the leading software in patient alarm management. David served communities and industries with a focus on customer service excellence, value driven products and services. The creation and development of Connexall would be his greatest achievement and the pride of making a marked difference in the technological evolution in healthcare. His belief that Connexall could help save lives would drive his passion and dedication to development with hospitals.

LinkedIn: https://www.linkedin.com/company/connexallgss
Facebook: https://www.facebook.com/ConnexallGSS
Twitter: https://twitter.com/ConnexallGSS

SOURCE Connexall USA Inc.


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: